On the 15th January 2021, UK Research and Innovation (UKRI) announced the launch of a new national research project to study the effects of emerging mutations in SARS-CoV-2. The consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, the effectiveness of vaccines and treatments. G2P will work alongside COG-UK and Public Health England to boost the UK’s capacity to study newly identified virus variants and rapidly inform government policy.
The G2P-UK National Virology Consortium
